In the 20th century, we began to die slowly—from our own biology, rather than plagues or predators. Fast deaths are now the exception, not the rule. Today, some 45 million deaths a year owe to biological aging, and we treat these deaths as mostly inevitable. But what if they are not? What if preventing our newly slow deaths is a moral and economic imperative? Drawing on interviews with 102 scientists and original economic modeling, Dr. Romanni-Klein reveals why advancing progress in the young science of aging may offer the highest social return of all possible investments in biomedical research. New advancements that redesign how we age and die as a species could soon make for the most impactful breakthrough in human history. If we could truly reverse biological aging, we’d add trillions to GDP—and more meaning to life.Raiany Romanni-Klein is founder of the Institute for Life and Technology, a new 501c3 designed to streamline and quantify progress in U.S. science and technology. She is also a Scholar-in-Residence at the American Federation for Aging Research. Previously, she helped design and launch the $101 million Healthspan XPRIZE, and was based at the Amaranth Foundation and the Wyss Institute at Harvard University.Aging, Bioethics, Biotech, Economics, Ethics, Global issues, Health, Humanity Raiany Romanni-Klein is founder of the Institute for Life and Technology, a new 501c3 designed to streamline and quantify progress in U.S. science and technology. She is also a Scholar-in-Residence at the American Federation for Aging Research. Previously, she helped design and launch the $101 million Healthspan XPRIZE, and was based at the Amaranth Foundation and the Wyss Institute at Harvard University. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx